跳至主要内容
临床试验/IRCT20161219031463N2
IRCT20161219031463N2已完成2 期

Study of adding Boswellia serrata resin to therapy of patients with mild to moderate Alzheimer's disease on cognitive status compared with placebo

Mashhad University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
55 years 至 82 years(—)
性别
All

入选标准

  • Patients with mild to moderate Alzheimer's disease based on the score of the MMSE test between 10-23

排除标准

  • Diagnosis of Alzheimer's disease less than 6 months before entering the study
  • Using cholinesterase inhibitors and / or memantine less than 90 days before entering the study or discontinuing them less than 90 days before entering the study
  • Use of other drugs and substances such as ginkgo biloba or vitamin E that affect cognitive status less than 60 days before entering the study or discontinued less than 90 days before entering the study.
  • Vascular dementia, thyroid disease, vitamin B12 deficiency, anemia, Lewy body dementia, liver function disorders, brain tumors, ischemic cerebrovascular accidents

研究者

相似试验